Predicting disease progression after regional therapy for in-transit melanoma.
about
Burden of disease predicts response to isolated limb infusion with melphalan and actinomycin D in melanoma.The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options.Isolated limb perfusion in Merkel cell carcinoma offers high rate of complete response and durable local-regional control: Systematic review and institutional experience.Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients.
P2860
Predicting disease progression after regional therapy for in-transit melanoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Predicting disease progression after regional therapy for in-transit melanoma.
@en
Predicting disease progression after regional therapy for in-transit melanoma.
@nl
type
label
Predicting disease progression after regional therapy for in-transit melanoma.
@en
Predicting disease progression after regional therapy for in-transit melanoma.
@nl
prefLabel
Predicting disease progression after regional therapy for in-transit melanoma.
@en
Predicting disease progression after regional therapy for in-transit melanoma.
@nl
P2093
P2860
P1433
P1476
Predicting disease progression after regional therapy for in-transit melanoma.
@en
P2093
Douglas S Tyler
Ketan Sharma
Michael E Lidsky
Ryan S Turley
P2860
P304
P356
10.1001/JAMASURG.2013.695
P407
P577
2013-06-01T00:00:00Z